bioethics deliberation and education
SESSION ONE: VIDEO MESSAGE
ROUNDTABLE DISCUSSION:
DR. GUTMANN: This is always, for the commission, one of the best opportunities. We have a – we have a tradition, which is – well, the first – the first tradition is to get everybody seated. Bob is coming up, and Alex will be right here. Did you see Alex?
UNIDENTIFIED SPEAKER: He's on his way.
SESSION TWO: REFLECTING ON THE PAST, PRESENT, AND FUTURE IMPACT OF NATIONAL BIOETHICS ADVISORY BODIES
SESSION 3: REFLECTING ON THE PAST, PRESENT, AND FUTURE IMPACT OF NATIONAL BIOETHICS ADVISORY BODIES
DR. WAGNER: I think we’ll go ahead and get underway. Fortunately, we’ve all had a chance to review everyone’s bios and by the time I’m through reading, I suspect Steve will be with us. And we’re going to continue our discussion this afternoon on the future impact of national bioethics advisory bodies.
WELCOME AND OPENING REMARKS
SESSION 5: ROUNDTABLE DISCUSSION
DR. GUTMANN: Terrific. Thank you all for rejoining us. I want you to think about but I'm going to start with Nelson's question I want you each to give us one piece of advice. And I mean, really, one. Don't make the one I have my one piece of advice is, I have ten pieces of advice. One thing that you would like to see addressed in our report having to do with what we could recommend to encourage or enable our society to improve the quality of deliberation or and/or education around issues of health science, bioethical issues.
SESSION 4: FOSTERING AND MEASURING SUCCESS IN ETHICS AND DELIBERATION
DR. GUTMANN: Welcome. Our first panelist is Carol Ripple, Associate Director for Education Research and Engagement in the Social Science Research Institute at Duke University. Dr. Ripple leads the education and human development incubator and oversees evaluation, data infrastructure, and community engagement.
SESSION 3: ETHICAL AND DELIBERATIVE SKILLS ACROSS THE LIFESPAN
DR. GUTMANN: If I could ask Commission members and everybody to take a seat, welcome back.
We are going to dive into a discussion of ethical and deliberative skills across the lifespan, and we are honored to begin with Sue Knight, who joins us from halfway around the world.
SESSION 2: FLUENCY IN SCIENCE AND ETHICS
DR. GUTMANN: We are now turning to the topic of fluency in science and ethics, and I have the pleasure, the distinct pleasure of introducing our very own Executive Director, Lisa M. Lee, to begin our panel.
Prior to joining us at the Bioethics Commission, Dr. Lee spent 14 years at the Centers for Disease Control and Prevention, CDC, where she held several leadership positions, including the agency's Assistant Science Officer and the Director of the Office of Science Integrity.
Pages
This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.